Clinical Trial: Clinical Outcome aNd Quality of life of intrathecal chemotherapy through Ommaya reservoir in combination with systematic chemotherapy versus systematic chemotherapy Upon Her-2 negative brEast canceR with leptomeningeal metastasis: a multi-center, randomized controlled, open-label study (CONQUER) (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Outcome aNd Quality of life of intrathecal chemotherapy through Ommaya reservoir in combination with systematic chemotherapy versus systematic chemotherapy Upon Her-2 negative brEast canceR with leptomeningeal metastasis: a multi-center, randomized controlled, open-label study (CONQUER)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132601

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=243128

Published by HT Digital Content Ser...